|
|
|
|
- Dr. Neil Friedman, MBChB, Paediatric Neurologist, Centre fo Paediatric Nerology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
|
|
|
- Dr. Jaishen Rajah, MD, Senior Paedistric Consultant, Sheikh Khalifa Medical Centre, Abu Dhabi, UAE
|
| |
| |
| |
|
|
-
Dr. Nawal Al Kaabi, Head Infectious Disease, Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
|
|
- Dr. Mohammed Taleb Alsamri, MD, Assistant Professor and Consultant, Paediatric Pulmonogy, Department of Paediatrics, FMHS, UAE University, Al Ain, UAE
|
| |
- Dr. Zeinab Alloub, Consultant General Paediatrics, Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
| |
- Dr. Peter Arkwright, FRCPH, D Phil, Consultant Paediatric Immunologist, Senior Lecturer, Honorary Consultant, Royal Manchester Childrens's Hospital, UK
|
| |
- Dr. Andrew Curran, Consultant Paediatric Neurologist, Alder Hey, Liverpool, UK
|
| |
-
Dr. Tayseer El-Hassan, MBBS, MRCPCH, FRCPCH, Paediatric Specialist, Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
| |
-
Dr. Alaa Eldemerdash, MD, FAAP, Head Section and Consultant, Neonatology, Al Wasl Hospital, Dubai, UAE
|
| |
- Dr. Jacquelyn Evans, FRCP, FAAP, Medical Director, Newborn/Infant Intensive Care Unit, The Children's Hospital of Philadelphia, USA
|
| |
- Dr. Alan Flake, FACS, FAAP, Director, Centre for Fetal Research, The Children's Hospital of Philadelphia, Philadelphia, USA,
|
| |
-
Professor Helen Foster, Professor of Paediatric Rheumatology, Newcastle University, Honorary Consultant Paediatric Rheumatologist, Great North Children’s Hospital, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
|
| |
- Dr. Marc Harrison, MD, Chief Executive Officer, Cleveland Clinic, Abu Dhabi, UAE
|
| |
-
Dr. Afrozul Haq, Senior Clinical Scientist, Pathology and Laboratory Medicine Institute, SKMC, Abu Dhabi, UAE
|
| |
- Dr. Ajay Kaul, MBBS, MD, Associate Professor of Paediatrics, Cincinnati Children's Hospital Medical Centre, Ohio, USA
|
| |
-
Dr. Peter Kim, Vice President, The Sheikh Zayed Institute for Paediatric Surgical Innovation, Associate Surgeon-in-Chief, Children’s National Medical Center, Washington, USA
|
| |
- Dr. Shabir A. Madhi, Executive Director, National Institute for Communicable Diseases, President of the World Paediatric Infectious Disease Society, Johannesburg, South Africa
|
| |
-
Dr. Khalid Mohamed, Consultant and Head, Paediatric Neurology, Qatar, Doha
|
| |
- Dr. Zulf Mughal, Consultant in Paediatric Bone Disorders, Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK
|
| |
-
Dr. P.K. Rajiv, MBBS, DCH, MD, Fellowship in Neonatology (Australia), Head of Newborn Division, NMC Speciality Hospital, Dubai, UAE
|
| |
-
Dr. Alan B. Retik, MD, Urologist-in-Chief, Executive Chair/Medical Director, International Health Services Children's Hospital Boston, Boston, USA
|
| |
-
Dr. Zbigniew Ruszczak, Consultant, Dermatology, Medical Institute, Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
| |
- Dr. Yazan Said, MD, ABP, ABAI, Consultant, Allergy/Clinical Immunology and Paediatric Pulmonolgy, Kind Fahad Specialist Hospital, Damman, Saudi Arabia
|
| |
- Dr. Souheil Shabib, Paediatric Gastroenterologist, Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
| |
- Dr. Syed Shah, Dermatologist, America Hospital, Dubai, UAE
|
| |
- Dr. Yasser Sharif, Section Head, Medication and Medical Products Safety and Manager of Poison and Drug Information Centre, HAAD, Abu Dhabi, UAE
|
| |
-
Dr. Marc F. Sinclair, Paediatric Orthopaedic Surgeon, The Children’s Medical Center, Dubai, UAE
|
| |
-
Dr. Hesham Soliman El Safoury, Consultant Paediatric Surgeon, Sheikh Khalifa Medical City, Abu Dhabi, UAE
|
| |
-
Dr. Marshall L. Summar, Chief, Division of Genetics and Metabolism, Children’s National Medical Center, Washington, D.C., USA
|
| |
|
|
Faculty Disclosure Statement:
The Cleveland Clinic Foundation Centre for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus. |